Reply to Zhu et al.: Implications of and in the pathobiology of myasthenia gravis.
作者信息
Chia Ruth, Saez-Atienzar Sara, Drachman Daniel B, Traynor Bryan J
机构信息
Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892.
Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287.
出版信息
Proc Natl Acad Sci U S A. 2022 Sep 9;119(36):e2209096119. doi: 10.1073/pnas.2209096119. Epub 2022 Aug 15.
Abstract
摘要
相似文献
1
Reply to Zhu et al.: Implications of and in the pathobiology of myasthenia gravis.对朱等人的回复：[具体内容]和[具体内容]在重症肌无力病理生物学中的意义。 （注：原文中“and”前后的具体内容缺失）
Proc Natl Acad Sci U S A. 2022 Sep 9;119(36):e2209096119. doi: 10.1073/pnas.2209096119. Epub 2022 Aug 15.
2
Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.重症肌无力的遗传风险基因座鉴定和基因及通路的优先级排序：全基因组关联研究。
Proc Natl Acad Sci U S A. 2022 Feb 1;119(5). doi: 10.1073/pnas.2108672119.
3
Clinical and scientific aspects of acetylcholine receptor myasthenia gravis.乙酰胆碱受体重症肌无力的临床与科学方面
Curr Opin Neurol. 2014 Oct;27(5):552-7. doi: 10.1097/WCO.0000000000000125.
4
Novel genes/loci validate the small effect size of ERBB2 in patients with myasthenia gravis.新基因/基因座证实了ERBB2在重症肌无力患者中的微小效应大小。
Proc Natl Acad Sci U S A. 2022 Sep 9;119(36):e2207273119. doi: 10.1073/pnas.2207273119. Epub 2022 Aug 15.
5
[Familial myasthenia gravis: report of 2 brothers].[家族性重症肌无力：两兄弟的病例报告]
Arq Neuropsiquiatr. 1985 Mar;43(1):80-5.
6
Onset and Evolution of Clinically Apparent Myasthenia Gravis After Resection of Non-myasthenic Thymomas.非肌无力性胸腺瘤切除术后临床明显重症肌无力的发病与进展
Semin Thorac Cardiovasc Surg. 2018 Summer;30(2):222-227. doi: 10.1053/j.semtcvs.2018.02.027. Epub 2018 Mar 6.
7
Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis.胸腺瘤伴或不伴重症肌无力的基因表达谱改变与重症肌无力发病的核因子-κB/自身免疫调节因子通路有关。
Thorac Cancer. 2019 Mar;10(3):564-570. doi: 10.1111/1759-7714.12980. Epub 2019 Feb 7.
8
Myasthenia gravis in identical twins.同卵双胞胎中的重症肌无力。
Neurology. 1986 Jan;36(1):78-80. doi: 10.1212/wnl.36.1.78.
9
Assessment of pre and post-thymectomy myasthenia gravis.胸腺切除术前和术后重症肌无力的评估
Neurol Res. 2019 Mar;41(3):275-281. doi: 10.1080/01616412.2018.1557433. Epub 2018 Dec 21.
10
[Thymectomy in the treatment of myasthenia gravis].[胸腺切除术治疗重症肌无力]
Zhonghua Yi Xue Za Zhi. 1998 May;78(5):363-5.
引用本文的文献
1
The shared genetic etiology of autoimmune disorders and interstitial lung disease: insights from large-scale genome-wide cross-trait analysis.自身免疫性疾病和间质性肺疾病的共同遗传病因：来自大规模全基因组跨性状分析的见解。
Clin Exp Med. 2025 Aug 27;25(1):305. doi: 10.1007/s10238-025-01836-3.
2
Assessment of bidirectional relationships between autoimmune diseases and primary ovarian insufficiency: insights from a bidirectional two-sample Mendelian randomization analysis.双向自身免疫性疾病与原发性卵巢功能不全关系的评估：来自双向两样本 Mendelian 随机分析的见解。
Arch Gynecol Obstet. 2024 Jun;309(6):2853-2861. doi: 10.1007/s00404-024-07482-6. Epub 2024 Mar 29.
3
Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis.整合多组学分析确定了重症肌无力的遗传支持药物靶点和免疫细胞特异性。
J Transl Med. 2024 Mar 24;22(1):302. doi: 10.1186/s12967-024-04994-2.
本文引用的文献
1
Novel genes/loci validate the small effect size of ERBB2 in patients with myasthenia gravis.新基因/基因座证实了ERBB2在重症肌无力患者中的微小效应大小。
Proc Natl Acad Sci U S A. 2022 Sep 9;119(36):e2207273119. doi: 10.1073/pnas.2207273119. Epub 2022 Aug 15.
2
Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.重症肌无力的遗传风险基因座鉴定和基因及通路的优先级排序：全基因组关联研究。
Proc Natl Acad Sci U S A. 2022 Feb 1;119(5). doi: 10.1073/pnas.2108672119.
3
An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci.系统地优先考虑所有已发表的人类 GWAS 性状关联基因座的因果变异和基因的开放方法。
Nat Genet. 2021 Nov;53(11):1527-1533. doi: 10.1038/s41588-021-00945-5. Epub 2021 Oct 28.
4
Open Targets Platform: supporting systematic drug-target identification and prioritisation.Open Targets 平台：支持系统性药物靶点识别和优先级排序。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1302-D1310. doi: 10.1093/nar/gkaa1027.
5
Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics.开放靶点遗传学：利用大规模遗传学和功能基因组学系统地识别与性状相关的基因。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1311-D1320. doi: 10.1093/nar/gkaa840.
6
A genetics-led approach defines the drug target landscape of 30 immune-related traits.遗传学主导的方法定义了 30 种免疫相关特征的药物靶点景观。
Nat Genet. 2019 Jul;51(7):1082-1091. doi: 10.1038/s41588-019-0456-1. Epub 2019 Jun 28.
7
Induction of acetylcholine receptor gene expression by ARIA requires activation of mitogen-activated protein kinase.ARIA诱导乙酰胆碱受体基因表达需要丝裂原活化蛋白激酶的激活。
J Biol Chem. 1996 Aug 16;271(33):19752-9. doi: 10.1074/jbc.271.33.19752.
8
ErbB3 and ErbB2/neu mediate the effect of heregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate.
EMBO J. 1995 Sep 1;14(17):4258-66. doi: 10.1002/j.1460-2075.1995.tb00100.x.
Zotero 插件